APPLY TREATMENT TO CLINICAL SYNDROMES
Urinary Tract Infections
Urinary infection treatment depends on the location of disease, systemic involvement, patient characteristics, and likely susceptibility. Bladder infection, pyelonephritis, prostatitis, and catheter-associated infection require different decisions.
Bacteriuria and pyuria are findings that require interpretation. Neither independently establishes symptomatic infection (Durham, 2026).
Distinguish the Syndrome
Dysuria, frequency, urgency, and suprapubic discomfort support lower urinary infection. Fever, flank pain, costovertebral angle tenderness, nausea, or systemic illness raise concern for pyelonephritis or another infection extending beyond the bladder.
Consider vaginitis, urethritis, sexually transmitted infection, stones, and noninfectious bladder symptoms when the presentation is atypical.
Confusion or a fall in an older adult should not automatically be attributed to a positive urine test. Assess alternative causes and whether localizing urinary or systemic infectious findings are present (Durham, 2026).
Use Testing Appropriately
A urine culture is particularly important with pyelonephritis, pregnancy, recurrent infection, treatment failure, suspected resistance, or a complicated presentation.
Collect a specimen that limits contamination. Interpret the organism, colony count, collection method, and symptoms together.
Asymptomatic bacteriuria generally does not require treatment. Important exceptions include pregnancy and selected invasive urologic procedures. Unnecessary treatment increases adverse effects and selective pressure without establishing benefit (Durham, 2026).
Acute Uncomplicated Cystitis
For a nonpregnant adult woman with infection confined to the bladder, representative options include:
- Nitrofurantoin monohydrate/macrocrystals 100 mg orally twice daily for five days
- Trimethoprim-sulfamethoxazole 160/800 mg orally twice daily for three days when the isolate is susceptible or local Escherichia coli resistance does not exceed 20%
- Fosfomycin tromethamine 3 g orally once
These regimens are not interchangeable across all patients. Kidney function, allergy, pregnancy, interactions, previous cultures, and recent exposure affect selection.
Nitrofurantoin and oral fosfomycin should not be used for pyelonephritis because bladder-focused exposure does not provide adequate treatment of renal parenchymal infection (Durham, 2026).
Pyelonephritis and Infection Beyond the Bladder
Obtain a culture and assess for sepsis, obstruction, inability to tolerate oral treatment, and need for hospitalization.
A representative oral regimen for a suitable adult is levofloxacin 750 mg daily for five days, with renal adjustment when indicated. Susceptibility, prior fluoroquinolone exposure, and adverse-effect risk determine whether this is appropriate. An initial parenteral agent may be needed when resistance makes empiric oral coverage uncertain.
Culture-directed alternatives require attention to tissue exposure and dosing. A susceptible urine isolate alone does not establish that a low-dose oral beta-lactam regimen will be adequate (Durham, 2026).
Current IDSA guidance supports 5–7 days of a fluoroquinolone or seven days of a nonfluoroquinolone for selected clinically improving patients with complicated UTI, including pyelonephritis. Duration is counted from the first effective treatment day. Supporting studies often excluded major complicating conditions, and short-course oral beta-lactam evidence is more limited. Suspected prostatitis, abscess, obstruction, severe illness, or other exclusions require individualized duration (Infectious Diseases Society of America [IDSA], 2025).
Bacterial Prostatitis
Fever, urinary symptoms, pelvic or perineal pain, and obstructive symptoms should prompt consideration of acute bacterial prostatitis. Avoid vigorous prostatic massage in suspected acute infection.
Treatment requires an agent that reaches prostatic tissue. Culture-directed fluoroquinolone or trimethoprim-sulfamethoxazole therapy may be appropriate in selected patients. Severe illness may require initial intravenous treatment.
Acute bacterial prostatitis commonly requires two to four weeks of effective therapy, guided by response and culture results. Chronic bacterial prostatitis may require several weeks of treatment. Persistent fever, urinary retention, or inadequate response warrants evaluation for complications, including abscess (Durham, 2026).
Catheter-Associated Infection
Indwelling catheters commonly lead to bacteriuria. Treat symptomatic infection rather than the culture alone.
Review whether the catheter remains necessary. Remove it when possible. If a catheter must remain and has been in place for at least two weeks at the onset of infection, replace it when it is still indicated and obtain the culture from the newly placed catheter. Obtain a properly collected culture, preferably from a newly replaced catheter when replacement is indicated.
Source management, systemic findings, and susceptibility guide therapy. Routine treatment of catheter-associated asymptomatic bacteriuria is generally inappropriate (Durham, 2026).
Recurrent Infection and Prevention
Confirm that recurrent episodes are symptomatic infections and review prior cultures. Rapid recurrence with the same organism may suggest persistence or an unresolved source.
Prevention may include addressing contributing behaviors, vaginal estrogen for eligible peri- or postmenopausal patients, and selected nonantibiotic or antibiotic strategies. Methenamine and prophylactic antibiotics require individualized assessment of contraindications, interactions, effectiveness, and patient preference.
Repeated empiric treatment without reassessing the diagnosis can expose patients to harm while missing an alternative cause (Durham, 2026).
Follow-Up
Symptoms should begin improving within the expected early treatment interval. Reassess persistent or worsening illness, and review culture results promptly.
Escalate care for hypotension, systemic toxicity, obstruction, severe pain, inability to maintain hydration, or pregnancy with suspected upper urinary infection. Routine test-of-cure cultures are generally unnecessary after resolved uncomplicated cystitis in nonpregnant patients.
Related YourDNP Resources
Content last reviewed:
References
Infectious Diseases Society of America. (2019). Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update. https://www.idsociety.org/practice-guideline/asymptomatic-bacteriuria/
Durham, S. H. (2026). Urinary tract infections. In M. A. Chisholm-Burns, P. M. Malone, J. M. Kolesar, K. C. Lee, P. B. Bookstaver, & K. R. Matthias (Eds.), Pharmacotherapy principles & practice (7th ed.). McGraw Hill.
Infectious Diseases Society of America. (2025). IDSA 2025 guideline update on complicated urinary tract infections. https://www.idsociety.org/practice-guideline/complicated-urinary-tract-infections/